[Significance of efflux pumps in multidrug resistance of Gram-negative bacteria]

Medycyna Doswiadczalna I Mikrobiologia
|June 19, 2015
PubMed

Insights

Multidrug resistance in bacteria, a major medical challenge, is often driven by efflux pumps. These bacterial systems, particularly RND efflux systems in Gram-negative bacteria, expel various substances, contributing to antibiotic resistance.

Area of Science:

  • Microbiology
  • Molecular Biology
  • Biochemistry

Context:

  • Multidrug resistance (MDR) in bacteria poses a significant threat to modern medicine.
  • The overuse and misuse of antibiotics and chemotherapeutics in healthcare settings exacerbate MDR.
  • Efflux pumps and their systems are increasingly recognized as key contributors to bacterial MDR.

Purpose:

  • To highlight the role of efflux pumps, specifically RND efflux systems in Gram-negative bacteria, in the phenomenon of multidrug resistance.
  • To explain how these efflux systems contribute to resistance against a wide range of substrates.

Summary:

  • Multidrug resistance is a complex issue influenced by multiple bacterial resistance mechanisms.
  • RND efflux systems in Gram-negative bacteria are crucial determinants of MDR, transporting diverse substrates like antibiotics, dyes, and disinfectants.
  • Genes encoding efflux pumps can be located on bacterial chromosomes or mobile genetic elements like plasmids, further complicating resistance.

Impact:

  • Understanding efflux pump mechanisms is vital for developing strategies to combat bacterial resistance.
  • This research underscores the need for judicious use of antibacterial agents to mitigate the rise of MDR.
  • Efflux pump inhibitors could represent a future therapeutic avenue to restore antibiotic efficacy.

Related Concept Videos

Carrier-Mediated Transport01:06

Carrier-Mediated Transport

Carrier-mediated transport is a pivotal process in drug absorption, particularly for lipid-insoluble drugs, and encompasses facilitated diffusion and active transport. Facilitated diffusion allows drugs to move along their concentration gradient without energy expenditure, while active transport utilizes ATP to drive drug movement against this gradient.
Active transport involves two types of membrane-spanning transporters: uptake and efflux. Uptake transporters are expressed in the small...
1.6K
Development of Antibiotic Resistance01:30

Development of Antibiotic Resistance

Antibiotic resistance is a major public health concern that arises when bacteria evolve mechanisms to withstand the effects of antibiotic treatments. This resistance can be intrinsic, acquired through genetic mutations, or transferred between bacteria via horizontal gene transfer. The development of antibiotic resistance poses significant challenges in treating bacterial infections and necessitates ongoing research to develop new therapeutic strategies.Intrinsic resistance occurs when bacterial...
2.0K
Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and...
122
Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within...
43
Pharmacogenetics of Drug Transporters: P-Glycoprotein and Solute Carrier Transporters01:16

Pharmacogenetics of Drug Transporters: P-Glycoprotein and Solute Carrier Transporters

The pharmacogenetics of drug transporters is increasingly recognized as a critical factor influencing interindividual variability in drug absorption, distribution, and elimination. These membrane-bound proteins regulate drugs' movement across cellular barriers by actively pumping them out (efflux) or facilitating their uptake (influx). Among the major transporter families, ATP-binding cassette (ABC) and solute carrier (SLC) transporters play particularly prominent roles. Genetic polymorphisms...
147
Hepatic Drug Clearance: Role of Transporters01:14

Hepatic Drug Clearance: Role of Transporters

In the liver and bile canaliculi, influx and efflux transporters modification can influence intrinsic clearance. Transporters play a significant role in moving drugs within liver cells. Elaborate models, such as the Biopharmaceutical Classification System (BCS), are essential to relate transporters to drug disposition. This system categorizes drugs into four classes based on solubility and permeability, providing insights into elimination routes and the effects of transporters following oral...
372